| First Author | Kelley TJ | Year | 1998 |
| Journal | J Clin Invest | Volume | 102 |
| Issue | 6 | Pages | 1200-7 |
| PubMed ID | 9739054 | Mgi Jnum | J:115209 |
| Mgi Id | MGI:3690845 | Doi | 10.1172/JCI2357 |
| Citation | Kelley TJ, et al. (1998) Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 102(6):1200-7 |
| abstractText | It has been reported that exhaled nitric oxide levels are reduced in cystic fibrosis (CF) patients. We have examined the inducible isoform of nitric oxide synthase (iNOS) in the airways by immunostaining and found that iNOS is constitutively expressed in the airway epithelia of non-CF mouse and human tissues but essentially absent in the epithelium of CF airways. We explored potential consequences of lost iNOS expression and found that iNOS inhibition significantly increases mouse nasal trans-epithelial potential difference, and hindered the ability of excised mouse lungs to prevent growth of Pseudomonas aeruginosa. The absence of continuous nitric oxide production in epithelial cells of CF airways may play a role in two CF-associated characteristics: hyperabsorption of sodium and susceptibility to bacterial infections. |
